Clinical Trials Logo

Clinical Trial Summary

The investigators designed a study to assess whether thoracic paravertebral blocks using a combination of ropivacaine and dexmedetomidine prolong nerve block duration.


Clinical Trial Description

The investigators designed a study to assess whether thoracic paravertebral blocks using a combination of ropivacaine and dexmedetomidine prolong nerve block duration. The effects of dexmedetomidine have only been compared at lower doses. This trial examined the effect of greater dose of dexmedetomidine on thoracic paravertebral block analgesia duration. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03677115
Study type Interventional
Source China Medical University, China
Contact
Status Withdrawn
Phase Phase 4
Start date November 1, 2018
Completion date March 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT04596787 - Bilateral Thoracic Paravertebral Blocks in Obese and Non-obese Patients Undergoing Reduction Mammaplasty